GUMHDURDWPHZGZ-SFHVURJKSA-N
C29H32F2N8O2 — CID 126667431
Data last refreshed: (MolForge compound catalog, from PubChem)
About GUMHDURDWPHZGZ-SFHVURJKSA-N
GUMHDURDWPHZGZ-SFHVURJKSA-N (PubChem CID 126667431) has the molecular formula C29H32F2N8O2 and a molecular weight of 562.63 g/mol. Its IUPAC name is N-[4-(difluoromethoxy)-2-[(2S)-2-[(dimethylamino)methyl]pyrrolidin-1-yl]-5-[[4-(1-methylpyrrolo[3,2-b]pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide.
Molecular Properties
| Compound Name | GUMHDURDWPHZGZ-SFHVURJKSA-N |
|---|---|
| PubChem CID | 126667431 |
| Molecular Formula | C29H32F2N8O2 |
| Molecular Weight | 562.63 g/mol |
| Exact Mass | 562.26 |
| IUPAC Name | N-[4-(difluoromethoxy)-2-[(2S)-2-[(dimethylamino)methyl]pyrrolidin-1-yl]-5-[[4-(1-methylpyrrolo[3,2-b]pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide |
| SMILES | C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4cccnc34)n2)c(OC(F)F)cc1N1CCC[C@H]1CN(C)C |
| InChI | InChI=1S/C29H32F2N8O2/c1-5-26(40)34-21-14-22(25(41-28(30)31)15-24(21)39-13-7-8-18(39)16-37(2)3)36-29-33-12-10-20(35-29)19-17-38(4)23-9-6-11-32-27(19)23/h5-6,9-12,14-15,17-18,28H,1,7-8,13,16H2,2-4H3,(H,34,40)(H,33,35,36)/t18-/m0/s1 |
| InChIKey | GUMHDURDWPHZGZ-SFHVURJKSA-N |
| XLogP | 5.03 |
| TPSA | 100.44 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 562.63 |
| LogP ≤ 5 | 5.03 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126667431 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.